logo-loader

NetScientific portfolio company Vortex enters manufacturing partnership with STRATEC

Published: 07:59 01 Nov 2018 GMT

Scientist
The agreement is also aimed at increasing VTX-1's prominence in the clinical space

NetScientific PLC’s (LON:NSCI) portfolio company, Vortex BioSciences, has secured a global manufacturing agreement with German firm STRATEC Consumables GmbH to scale up production of its VTX-1 liquid biopsy platform.

The healthcare IP commercialisation firm said STRATEC would assist Vortex in producing a customised chip, a crucial component of its automated platform, as well as assisting the company with scaling up to commercial viability and increasing the product’s prominence in the clinical space as a diagnostic and monitoring tool.

WATCH: 'Pivotal' moment for NetScientific's Glycotest Inc with $10mln financing

Francois Martelet, chief executive of NetScientific and chairman of Vortex, said the partnership would help create a reproducible process that would “allow Vortex's technology to enter the market and readily address demand as it surges”.

NetScientific holds a 66.1% stake in Vortex.

Wanda Health discusses its recent AI developments

Wanda Health Inc CEO Tom Smith visits the Proactive London studio to speak with Thomas Warner after the Remote Patient Monitoring (RPM) company announced the start of a new fundraise. Smith gives an overview of what Wanda intends to do with the proceeds, highlighting the company's sharp focus...

on 16/1/24